NASDAQ:GILD   Gilead Sciences, Inc.
2
GILD has suffered over the past 3 quarters, but with a reshaping of its business, we could see them pushing up into positive territory again. Looking for a TL break and the momentum to continue.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.